FI932552A0 - Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen - Google Patents

Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen

Info

Publication number
FI932552A0
FI932552A0 FI932552A FI932552A FI932552A0 FI 932552 A0 FI932552 A0 FI 932552A0 FI 932552 A FI932552 A FI 932552A FI 932552 A FI932552 A FI 932552A FI 932552 A0 FI932552 A0 FI 932552A0
Authority
FI
Finland
Prior art keywords
foer
utloesningen
reglerad
doserformform
enhet
Prior art date
Application number
FI932552A
Other languages
English (en)
Finnish (fi)
Other versions
FI932552A (fi
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI932552A0 publication Critical patent/FI932552A0/fi
Publication of FI932552A publication Critical patent/FI932552A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI932552A 1990-12-07 1993-06-04 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen FI932552A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
FI932552A0 true FI932552A0 (fi) 1993-06-04
FI932552A FI932552A (fi) 1993-06-04

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932552A FI932552A (fi) 1990-12-07 1993-06-04 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen

Country Status (20)

Country Link
US (1) US5419918A (no)
EP (1) EP0560822B1 (no)
JP (1) JP3239319B2 (no)
AT (1) ATE130188T1 (no)
AU (1) AU659114B2 (no)
CA (1) CA2097175A1 (no)
DE (1) DE69114721T2 (no)
DK (1) DK0560822T3 (no)
ES (1) ES2079689T3 (no)
FI (1) FI932552A (no)
GR (1) GR3018685T3 (no)
HU (1) HUT64212A (no)
IE (1) IE914229A1 (no)
IS (1) IS3789A7 (no)
NO (1) NO932054D0 (no)
PL (1) PL168605B1 (no)
PT (1) PT99721A (no)
SE (1) SE9003904D0 (no)
WO (1) WO1992010169A1 (no)
YU (1) YU182091A (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
ES2179829T3 (es) 1992-09-18 2003-02-01 Yamanouchi Pharma Co Ltd Preparacion de hidrogel de liberacion prolongada.
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
SG11201508571WA (en) * 2013-04-16 2015-11-27 Murray And Poole Entpr Ltd Sustained-release formulations of colchicine and methods of using same
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CA1247852A (en) * 1983-12-20 1989-01-03 Akihiko Nomura Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
IS3789A7 (is) 1992-06-08
HUT64212A (en) 1993-12-28
CA2097175A1 (en) 1992-06-08
IE914229A1 (en) 1992-06-17
ATE130188T1 (de) 1995-12-15
AU659114B2 (en) 1995-05-11
AU8930991A (en) 1992-07-08
HU9301672D0 (en) 1993-09-28
US5419918A (en) 1995-05-30
DK0560822T3 (da) 1996-03-11
EP0560822A1 (en) 1993-09-22
GR3018685T3 (en) 1996-04-30
DE69114721D1 (de) 1995-12-21
NO932054L (no) 1993-06-04
EP0560822B1 (en) 1995-11-15
WO1992010169A1 (en) 1992-06-25
SE9003904D0 (sv) 1990-12-07
NO932054D0 (no) 1993-06-04
PL299376A1 (en) 1994-03-07
FI932552A (fi) 1993-06-04
PL168605B1 (pl) 1996-03-29
YU182091A (sh) 1994-04-05
ES2079689T3 (es) 1996-01-16
PT99721A (pt) 1993-04-30
JP3239319B2 (ja) 2001-12-17
JPH06503310A (ja) 1994-04-14
DE69114721T2 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
FI932552A0 (fi) Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
FI973733A0 (fi) Farmaceutiskt preparat och foerfarande foer dess framstaellning
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
NL189898C (nl) Vaste, farmaceutische doseringsvorm voor de orale toediening alsmede werkwijze ter vervaardiging daarvan.
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
FI93924B (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
ATE44279T1 (de) Gewisse benzazocinon- und benzazoninon-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
NO167204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser.
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
ATE111734T1 (de) Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
DK93485A (da) Farmaceutisk praeparat til behandling af hypertension og thromboemboliske sygdomme
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
DE69905490D1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
NO871195D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-piperazino-kinolin-3-karboksylsyre.

Legal Events

Date Code Title Description
FD Application lapsed